Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 4:05 PM View:  | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 01-Feb-23 | Market Sale (Planned) | 1,000 | $67.93 | $67,930.00 | (1%) 90.25K to 89.25K | (10%) |
| 18-Jan-23 4:09 PM View: | Doyle James Edward Director | EXACT Sciences Corp. (EXAS) | 13-Jan-23 | Option Exercise | 5,477 | $16.52 | $90,480.00 | 11% 48.44K to 53.91K | |
| 11-Jan-23 4:03 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 09-Jan-23 | Sale (Planned) | 1,000 | $60.00 | $60,000.00 | (1%) 91.25K to 90.25K | |
| 05-Jan-23 4:03 PM View: | Coward D Scott Director | EXACT Sciences Corp. (EXAS) | 03-Jan-23 | Grant | 7,780 | -- | -- | 37% 20.99K to 28.77K | |
| 13-Oct-22 8:57 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 12-Oct-22 | Planned Option Sale | 16,872 | $31.37 | $529,275.00 | (47%) 35.53K to 18.65K | |
| 13-Oct-22 8:57 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 11-Oct-22 | Option Exercise | 35,006 | -- | -- | 6732% 0.52K to 35.53K | |
| 08-Aug-22 4:02 PM View: | Baranick Brian Gen. Mgr., Precision Oncology | EXACT Sciences Corp. (EXAS) | 05-Aug-22 | Planned Option Sale | 984 | $47.12 | $46,366.10 | (17%) 5.74K to 4.75K | |
| 08-Aug-22 4:02 PM View: | Baranick Brian Gen. Mgr., Precision Oncology | EXACT Sciences Corp. (EXAS) | 04-Aug-22 | Option Exercise | 2,712 | -- | -- | 90% 3.03K to 5.74K | |
| 28-Jul-22 4:04 PM View: | Napier Katherine S Director | EXACT Sciences Corp. (EXAS) | 26-Jul-22 | Option Exercise | 4,608 | $10.18 | $46,909.40 | 7% 64.06K to 68.67K | |
| 28-Jul-22 4:04 PM View: | Napier Katherine S Director | EXACT Sciences Corp. (EXAS) | 26-Jul-22 | Planned Option Sale | 4,608 | $45.14 | $208,005.00 | (7%) 68.67K to 64.06K | |
| 06-Jul-22 4:11 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 01-Jul-22 | Sale | 7 | $40.75 | $285.25 | (< 1%) 1.22M to 1.22M | |
| 01-Jul-22 6:20 PM View: | Napier Katherine S Director | EXACT Sciences Corp. (EXAS) | 30-Jun-22 | Sale (Planned) | 1,086 | $40.13 | $43,581.20 | (2%) 65.14K to 64.06K | |
| 13-Jun-22 5:25 PM View: | Clancy Paul J Director | EXACT Sciences Corp. (EXAS) | 09-Jun-22 | Grant | 5,606 | -- | -- | 102% 5.5K to 11.1K | |
| 13-Jun-22 5:15 PM View: | Sebelius Kathleen Director | EXACT Sciences Corp. (EXAS) | 09-Jun-22 | Grant | 7,523 | -- | -- | 54% 13.88K to 21.4K | |
| 13-Jun-22 5:12 PM View: | Napier Katherine S Director | EXACT Sciences Corp. (EXAS) | 09-Jun-22 | Grant | 5,606 | -- | -- | 9% 59.54K to 65.14K | |
| 13-Jun-22 5:22 PM View: | Jacquet Pierre Director | EXACT Sciences Corp. (EXAS) | 09-Jun-22 | Grant | 7,243 | -- | -- | 62% 11.75K to 19.0K | |
| 13-Jun-22 5:19 PM View: | Lewis-Hall Freda C Director | EXACT Sciences Corp. (EXAS) | 09-Jun-22 | Grant | 5,606 | -- | -- | 53% 10.48K to 16.09K | |
| 13-Jun-22 5:17 PM View: | Petrovic Shacey Director | EXACT Sciences Corp. (EXAS) | 09-Jun-22 | Grant | 5,606 | -- | -- | 67% 8.36K to 13.96K | |
| 13-Jun-22 5:24 PM View: | Doyle James Edward Director | EXACT Sciences Corp. (EXAS) | 09-Jun-22 | Grant | 5,606 | -- | -- | 13% 42.83K to 48.44K | |
| 13-Jun-22 5:20 PM View: | Levangie Daniel J Director | EXACT Sciences Corp. (EXAS) | 09-Jun-22 | Grant | 5,606 | -- | -- | 32% 17.69K to 23.3K | |
| 08-Jun-22 4:02 PM View: | Doyle James Edward Director | EXACT Sciences Corp. (EXAS) | 07-Jun-22 | Option Exercise | 3,000 | $16.52 | $49,560.00 | 8% 39.83K to 42.83K | |
| 13-Oct-22 8:57 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 02-May-22 | Grant | 520 | $47.41 | $24,653.20 | 100% 0 to 0.52K | |
| 06-Jul-22 4:11 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 02-May-22 | Grant | 328 | $47.41 | $15,550.50 | < 1% 1.22M to 1.22M | |
| 11-Jan-23 4:03 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 02-May-22 | Grant | 328 | $47.41 | $15,550.50 | < 1% 90.92K to 91.25K | |
| 05-Jan-23 4:03 PM View: | Coward D Scott Director | EXACT Sciences Corp. (EXAS) | 02-May-22 | Grant | 328 | $47.41 | $15,550.50 | 2% 20.66K to 20.99K | |
| 18-Mar-22 4:22 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 17-Mar-22 | Option Exercise | 236,622 | $6.38 | $1,509,570.00 | 24% 979.3K to 1.22M | |
| 18-Mar-22 4:24 PM View: | Doyle James Edward Director | EXACT Sciences Corp. (EXAS) | 17-Mar-22 | Option Exercise | 10,000 | $16.52 | $165,200.00 | 34% 29.83K to 39.83K | |
| 02-Mar-22 5:22 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 01-Mar-22 | Planned Option Sale | 4,050 | $76.69 | $310,594.00 | (17%) 24.37K to 20.32K | |
| 02-Mar-22 5:31 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 01-Mar-22 | Planned Option Sale | 2,816 | $76.69 | $215,959.00 | (3%) 93.5K to 90.68K | |
| 02-Mar-22 5:28 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 01-Mar-22 | Planned Option Sale | 14,299 | $76.69 | $1,096,590.00 | (1%) 993.59K to 979.29K | |
| 02-Mar-22 5:25 PM View: | Coward D Scott Chief Legal Officer | EXACT Sciences Corp. (EXAS) | 01-Mar-22 | Planned Option Sale | 3,912 | $76.69 | $300,011.00 | (16%) 24.34K to 20.43K | |
| 02-Mar-22 5:31 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 28-Feb-22 | Option Exercise | 5,881 | -- | -- | 7% 87.62K to 93.5K | |
| 02-Mar-22 5:25 PM View: | Coward D Scott Chief Legal Officer | EXACT Sciences Corp. (EXAS) | 28-Feb-22 | Option Exercise | 8,288 | -- | -- | 52% 16.05K to 24.34K | |
| 02-Mar-22 5:22 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 28-Feb-22 | Option Exercise | 8,462 | -- | -- | 53% 15.91K to 24.37K | |
| 02-Mar-22 5:28 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 28-Feb-22 | Option Exercise | 29,887 | -- | -- | 3% 963.7K to 993.59K | |
| 01-Mar-22 10:00 PM View: | Condella Sarah SVP, Human Resources | EXACT Sciences Corp. (EXAS) | 25-Feb-22 | Market Sale (Planned) | 5,480 | $74.19 | $406,542.00 | (6%) 93.1K to 87.62K | (< 1%) |
| 25-Feb-22 6:43 PM View: | Condella Sarah SVP, Human Resources | EXACT Sciences Corp. (EXAS) | 24-Feb-22 | Planned Option Sale | 4,717 | $70.10 | $330,662.00 | (5%) 97.82K to 93.1K | |
| 25-Feb-22 6:40 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 24-Feb-22 | Planned Option Sale | 27,126 | $70.10 | $1,901,530.00 | (3%) 990.83K to 963.7K | |
| 25-Feb-22 6:31 PM View: | Orville Jacob A General Manager, New Ventures | EXACT Sciences Corp. (EXAS) | 24-Feb-22 | Planned Option Sale | 4,717 | $70.10 | $330,662.00 | (24%) 20.07K to 15.35K | |
| 25-Feb-22 6:37 PM View: | Coward D Scott Chief Administrative Officer | EXACT Sciences Corp. (EXAS) | 24-Feb-22 | Planned Option Sale | 5,815 | $70.10 | $407,632.00 | (27%) 21.87K to 16.05K | |
| 25-Feb-22 6:33 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 24-Feb-22 | Planned Option Sale | 5,897 | $70.10 | $413,380.00 | (27%) 21.8K to 15.91K | |
| 24-Feb-22 7:10 PM View: | Orville Jacob A General Manager, New Ventures | EXACT Sciences Corp. (EXAS) | 23-Feb-22 | Planned Option Sale | 1,125 | $69.05 | $77,681.20 | (10%) 10.99K to 9.87K | |
| 24-Feb-22 7:07 PM View: | Coward D Scott Chief Administrative Officer | EXACT Sciences Corp. (EXAS) | 23-Feb-22 | Planned Option Sale | 1,109 | $69.05 | $76,576.50 | (11%) 10.23K to 9.12K | |
| 25-Feb-22 6:33 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 23-Feb-22 | Option Exercise | 12,747 | -- | -- | 141% 9.06K to 21.8K | |
| 25-Feb-22 6:40 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 23-Feb-22 | Option Exercise | 58,643 | -- | -- | 6% 932.18K to 990.83K | |
| 24-Feb-22 7:20 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 23-Feb-22 | Planned Option Sale | 1,557 | $69.05 | $107,511.00 | (15%) 10.61K to 9.06K | |
| 25-Feb-22 6:37 PM View: | Coward D Scott Chief Administrative Officer | EXACT Sciences Corp. (EXAS) | 23-Feb-22 | Option Exercise | 12,747 | -- | -- | 140% 9.12K to 21.87K | |
| 24-Feb-22 7:16 PM View: | Condella Sarah SVP, Human Resources | EXACT Sciences Corp. (EXAS) | 23-Feb-22 | Planned Option Sale | 1,124 | $69.05 | $77,612.20 | (1%) 88.74K to 87.62K | |
| 24-Feb-22 7:14 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 23-Feb-22 | Planned Option Sale | 5,188 | $69.05 | $358,231.00 | (< 1%) 937.37K to 932.18K | |
| 25-Feb-22 6:31 PM View: | Orville Jacob A General Manager, New Ventures | EXACT Sciences Corp. (EXAS) | 23-Feb-22 | Option Exercise | 10,197 | -- | -- | 103% 9.87K to 20.07K |
